Expertise in
8
conditions

Otavio Berwanger

Av. Albert Einstein 627, 05651-90, 
Sao Paulo, SP, BR 
Expertise in
8
conditions
Av. Albert Einstein 627, 05651-90, 
Sao Paulo, SP, BR 

Overview

Otavio Berwanger practices practicing medicine in Sao Paulo, Brazil.

Mr. Berwanger is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Acute Coronary Syndrome, COVID-19, Severe Acute Respiratory Syndrome (SARS), Percutaneous Coronary Intervention (PCI), and Gastric Bypass.

He is actively involved in clinical research, co-authoring 204 peer reviewed articles and participating in 7 clinical trials.

Gender

Male

Locations

Av. Albert Einstein 627, 05651-90, Sao Paulo, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Effect of Polipill on Patients at High Cardiovascular Risk : a Randomized Controlled Trial
Effect of Polipill on Patients at High Cardiovascular Risk : a Randomized Controlled Trial
Enrollment Status: Withdrawn
Publish Date: September 21, 2022
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Phase 3, Multicenter, Open Label, Evaluating the Effect of the Treatment of Indapamide 1.5mg/Losartan 50mg and Indapamide 1.5mg/Losartan 100mg, Compared With Hyzaar® in the Treatment of Hypertension
Randomized, Phase 3, Multicenter, Open Label, Evaluating the Effect of the Treatment of Indapamide 1.5mg/Losartan 50mg and Indapamide 1.5mg/Losartan 100mg, Compared With Hyzaar® in the Treatment of Hypertension
Enrollment Status: Suspended
Publish Date: July 27, 2022
Intervention Type: Drug
Study Drugs: Indapamide+Losartan, Hyzaar®
Study Phase: Phase 3
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Pragmatic, Double-blind, Placebo-controlled Randomized Clinical Trial, Evaluating Hydroxychloroquine for Prevention of Hospitalization and Respiratory Complications in Non-hospitalized Patients With Confirmed or Probable COVID-19
Enrollment Status: Completed
Publish Date: March 07, 2022
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 4
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Evaluation of the Safety and Clinical Efficacy of Hydroxychloroquine Associated With Azithromycin in Patients With Pneumonia Caused by Infection by the SARS-CoV2 Virus - Coalition COVID-19 Brasil II - SEVERE - Patients
Enrollment Status: Completed
Publish Date: January 20, 2021
Intervention Type: Drug
Study Phase: Phase 3
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
Enrollment Status: Terminated
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Multicenter Clinical Trial to Assess the Effect of Atorvastatin in Patients With Acute Coronary Syndrome and Intended Percutaneous Coronary Intervention
A Randomized, Multicenter Clinical Trial to Assess the Effect of Atorvastatin in Patients With Acute Coronary Syndrome and Intended Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: June 17, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

203 Total Publications

Digitally Enabled Quality Improvement Intervention and LDL-C Control in Atherosclerotic Cardiovascular Disease: The SAPPHIRE-LDL Cluster Randomized Clinical Trial.
Digitally Enabled Quality Improvement Intervention and LDL-C Control in Atherosclerotic Cardiovascular Disease: The SAPPHIRE-LDL Cluster Randomized Clinical Trial.
Journal: JAMA cardiology
Published: July 22, 2026

Frequently Asked Questions about Otavio Berwanger

Is Otavio Berwanger a top-rated expert for Acute Coronary Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Otavio Berwanger is classified as an Distinguished expert for Acute Coronary Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Otavio Berwanger participate in research or clinical trials?

Yes. Otavio Berwanger has published 203 articles and abstracts on conditions like Acute Coronary Syndrome. You can view a list of Otavio Berwanger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Berwanger's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile